Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2015 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Over-Allotment Option

WESTLAKE VILLAGE, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the closing of its underwritten public offering of 2,994,793 shares of its...
March 10, 2015 21:52 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

WESTLAKE VILLAGE, Calif., March 10, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the pricing of its underwritten public offering of 2,604,168 shares of its...
March 09, 2015 16:01 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Proposed Public Offering of Common Stock

WESTLAKE VILLAGE, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has commenced an underwritten public offering of $125 million of shares of...
March 09, 2015 12:45 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces FDA Advisory Committee Unanimously (17-0) Recommends to Approve ATX-101 (deoxycholic acid) Injection to Improve the Appearance of Moderate to Severe Submental Fullness

WESTLAKE VILLAGE, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S. Food and Drug Administration's (FDA) Dermatologic and...
March 04, 2015 22:55 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., March 4, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that the Compensation Committee of the Company's Board of Directors granted...
March 02, 2015 16:56 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces 2014 Operating Results

WESTLAKE VILLAGE, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its quarter and year ended December 31, 2014, and...
February 10, 2015 16:22 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss

WESTLAKE VILLAGE, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has entered into separate license agreements with Actelion...
February 04, 2015 19:00 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference

WESTLAKE VILLAGE, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the...
February 04, 2015 16:22 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Submits Drug Application in Australia for Novel Submental Contouring Injectable Drug ATX-101

WESTLAKE VILLAGE, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced its submission to Australia's Therapeutic Goods Administration (TGA) for...
February 03, 2015 20:25 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on January 30, 2015, the Compensation Committee of the Company's Board of...